Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C M Jespersen

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
European Journal of Clinical Pharmacology|January 1, 1990
Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteersK Winther, C M Jespersen, B Rydberg, et al.
European Heart Journal|September 1, 1985
The prognostic value of maximal exercise testing soon after first myocardial infarctionC M Jespersen, E Kassis, C J Edeling, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Sustained-release and instant-release verapamil in treatment of angina pectorisC M Jespersen, N A Klitgaard, H Nielsen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Circadian variation in the pharmacokinetics of verapamilC M Jespersen, M Frederiksen, J F Hansen, et al.
The American Journal of Cardiology|June 20, 1996
Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fractionJ F Hansen, L Tingsted, V Rasmussen, et al.
Journal of Internal Medicine|January 1, 1993
Exercise-provoked ST-segment depression and prognosis in patients recovering from acute myocardial infarction. Significance and pitfallsC M Jespersen, L Hagerup, N Holländer, et al.
The Journal of Antimicrobial Chemotherapy|May 30, 2009
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trialC M Jespersen, H J Kolmos, N Frydendall, et al.
Journal of Hypertension|December 1, 1983
Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal womenC M Jespersen, K Arnung, C Hagen, et al.
Ugeskrift for Laeger|July 6, 1987
[Estrogen/gestagen induced hypertension. A follow-up study on treatment and subsequent occurrence of hypertension]C M Jespersen, H A Albrechtsen, C A Olsen, et al.
Journal of Internal Medicine|January 1, 1993
Does exercise-induced ST-segment depression predict benefit of medical intervention in patients recovering from acute myocardial infarction? The Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen, L Hagerup, N Holländer, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
European Journal of Clinical Pharmacology|January 1, 1990
Dose-dependent effects of verapamil and nifedipine on in vivo platelet function in normal volunteersK Winther, C M Jespersen, B Rydberg, et al.
European Heart Journal|September 1, 1985
The prognostic value of maximal exercise testing soon after first myocardial infarctionC M Jespersen, E Kassis, C J Edeling, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Sustained-release and instant-release verapamil in treatment of angina pectorisC M Jespersen, N A Klitgaard, H Nielsen, et al.
European Journal of Clinical Pharmacology|January 1, 1989
Circadian variation in the pharmacokinetics of verapamilC M Jespersen, M Frederiksen, J F Hansen, et al.
The American Journal of Cardiology|June 20, 1996
Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fractionJ F Hansen, L Tingsted, V Rasmussen, et al.
Journal of Internal Medicine|January 1, 1993
Exercise-provoked ST-segment depression and prognosis in patients recovering from acute myocardial infarction. Significance and pitfallsC M Jespersen, L Hagerup, N Holländer, et al.
The Journal of Antimicrobial Chemotherapy|May 30, 2009
Compliance with and short-term adverse events from clarithromycin versus placebo in patients with stable coronary heart disease: the CLARICOR trialC M Jespersen, H J Kolmos, N Frydendall, et al.
Journal of Hypertension|December 1, 1983
Effects of natural oestrogen therapy on blood pressure and renin-angiotensin system in normotensive and hypertensive menopausal womenC M Jespersen, K Arnung, C Hagen, et al.
Ugeskrift for Laeger|July 6, 1987
[Estrogen/gestagen induced hypertension. A follow-up study on treatment and subsequent occurrence of hypertension]C M Jespersen, H A Albrechtsen, C A Olsen, et al.
Journal of Internal Medicine|January 1, 1993
Does exercise-induced ST-segment depression predict benefit of medical intervention in patients recovering from acute myocardial infarction? The Danish Study Group on Verapamil in Myocardial InfarctionC M Jespersen, L Hagerup, N Holländer, et al.
Pageof 4